Le Lézard
Classified in: Health
Subjects: AWD, VET

Mako Medical Laboratories Awarded by the U.S. Department of Labor for Its Military Programs


TAMPA, Fla., Feb. 8, 2020 /PRNewswire/ -- The U.S. Department of Labor has recognized Mako Medical for their extensive programs focused on military veterans.

The Honoring Investments in Recruiting and Employing American Military Veterans Act 2017 (HIRE Vets Act or the Act) was signed by President Trump and requires the Secretary of Labor to establish a program, by rule, that recognizes employer efforts to recruit, employ and retain veterans. The criteria for winning the award included the number of veterans hired, the number of veterans retained for at least 12 months, the number of new hires that were veterans, training programs implemented to help veterans, leadership opportunities during employment for veterans and special programs built for veterans employed at the company. To earn a Hire Vets Medallion Award, job creators must demonstrate a solid commitment to providing veterans with the opportunities.

"Mako Medical laboratories has focused on building entire programs around Military Veterans. We carved out entire decisions of the company that are reserved only for military veterans," says Adam Price Co-founder of Mako Medical and director of military programs at Mako. "I am a combat veteran myself and know how hard it is for our veterans to transition back into civilian life." 

Mako Medical has built training and leadership programs, works with the National Guard to help with transitioning active-duty members, has formed partnerships with community colleges, and has created a culture that puts veterans first. MakoCares was recently added and allows veterans on the team that are struggling or going through a hard time to apply for financial assistance from the company. It is run and administered by other employees at Mako and operates confidently.

Mako Medical and Mako Medical Laboratories is a healthcare company focused on disrupting healthcare by using technology and new innovative processes. Mako Medical is known for its extensive community service, hiring military veterans, and supporting Christian missionaries around the world.

[email protected]

Related Images

image1.jpeg

Related Links

http://makomedical.com

SOURCE Mako Medical Laboratories


These press releases may also interest you

at 07:08
Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter...

at 07:05
Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin
Bruker Corporation is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR...

at 07:05
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today...

at 07:05
Satellos Presents Preliminary Data Showing Muscle Repair and Regeneration from SAT-3247 Treatment in Canine Model of Duchenne Muscular Dystrophy ("DMD")
Satellos Bioscience Inc. ("Satellos" or the "Company") , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced preliminary results from a single case...

at 07:00
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program with Initial Focus on Inflammatory Gastrointestinal Disease Ulcerative Colitis
ThirtyFiveBio Limited,...

at 07:00
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency
DRI Healthcare Trust (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS...

More news about Health...


News published on and distributed by: